| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACVRL1
|
activin A receptor type II-like 1
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADGRE5
|
adhesion G protein-coupled receptor E5
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGO2
|
argonaute RISC catalytic component 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALL1
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APC
|
adenomatous polyposis coli
|
|
APIP
|
APAF1 interacting protein
|
|
APOA1
|
apolipoprotein A-I
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
APOF
|
apolipoprotein F
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARF4
|
ADP-ribosylation factor 4
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
ASH2L
|
ash2 (absent, small, or homeotic)-like (Drosophila)
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
BAHD1
|
bromo adjacent homology domain containing 1
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2L1
|
BCL2-like 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRAP
|
BRCA1 associated protein
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRI3
|
brain protein I3
|
|
CALB1
|
calbindin 1, 28kDa
|
|
CALB2
|
calbindin 2
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA1
|
cyclin A1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD1D
|
CD1d molecule
|
|
CD4
|
CD4 molecule
|
|
CD6
|
CD6 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDH7
|
cadherin 7, type 2
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK11B
|
cyclin-dependent kinase 11B
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CENPE
|
centromere protein E, 312kDa
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CFB
|
complement factor B
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHAF1A
|
chromatin assembly factor 1, subunit A (p150)
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CLOCK
|
clock circadian regulator
|
|
CLU
|
clusterin
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
COMT
|
catechol-O-methyltransferase
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CREB3
|
cAMP responsive element binding protein 3
|
|
CREBBP
|
CREB binding protein
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSMD1
|
CUB and Sushi multiple domains 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CUL3
|
cullin 3
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL2
|
chemokine (C-X-C motif) ligand 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP7A1
|
cytochrome P450, family 7, subfamily A, polypeptide 1
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DPY19L2
|
dpy-19-like 2 (C. elegans)
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
DYNC1H1
|
dynein, cytoplasmic 1, heavy chain 1
|
|
DZIP3
|
DAZ interacting zinc finger protein 3
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F2
|
E2F transcription factor 2
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
E2F6
|
E2F transcription factor 6
|
|
ECE2
|
endothelin converting enzyme 2
|
|
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F10
|
coagulation factor X
|
|
F9
|
coagulation factor IX
|
|
FAM53B
|
family with sequence similarity 53, member B
|
|
FBP1
|
fructose-1,6-bisphosphatase 1
|
|
FCRL3
|
Fc receptor-like 3
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXG1
|
forkhead box G1
|
|
FOXO1
|
forkhead box O1
|
|
FPGT
|
fucose-1-phosphate guanylyltransferase
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GALNT12
|
polypeptide N-acetylgalactosaminyltransferase 12
|
|
GBA
|
glucosidase, beta, acid
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2
|
|
GNB1
|
guanine nucleotide binding protein (G protein), beta polypeptide 1
|
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GOT1
|
glutamic-oxaloacetic transaminase 1, soluble
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GP5
|
glycoprotein V (platelet)
|
|
GP9
|
glycoprotein IX (platelet)
|
|
GPC3
|
glypican 3
|
|
GRIN2A
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A
|
|
GRM7
|
glutamate receptor, metabotropic 7
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GZMA
|
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)
|
|
H2AFY
|
H2A histone family, member Y
|
|
HBB
|
hemoglobin, beta
|
|
HCP5
|
HLA complex P5 (non-protein coding)
|
|
HELLS
|
helicase, lymphoid-specific
|
|
HIRA
|
histone cell cycle regulator
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMGB2
|
high mobility group box 2
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HOXB4
|
homeobox B4
|
|
HOXC9
|
homeobox C9
|
|
HPX
|
hemopexin
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
HSPA1L
|
heat shock 70kDa protein 1-like
|
|
HSPA7
|
heat shock 70kDa protein 7 (HSP70B)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDS
|
iduronate 2-sulfatase
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGLV@
|
immunoglobulin lambda variable cluster
|
|
IL12B
|
interleukin 12B
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
IQCB1
|
IQ motif containing B1
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF8
|
interferon regulatory factor 8
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNK18
|
potassium channel, two pore domain subfamily K, member 18
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDM2A
|
lysine (K)-specific demethylase 2A
|
|
KDR
|
kinase insert domain receptor
|
|
KIAA0556
|
KIAA0556
|
|
KIAA1524
|
KIAA1524
|
|
KIF2C
|
kinesin family member 2C
|
|
KIR2DS4
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KMT2E
|
lysine (K)-specific methyltransferase 2E
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
LAT
|
linker for activation of T cells
|
|
LCN1
|
lipocalin 1
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LRRTM3
|
leucine rich repeat transmembrane neuronal 3
|
|
LTF
|
lactotransferrin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAOA
|
monoamine oxidase A
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCPH1
|
microcephalin 1
|
|
MEIS2
|
Meis homeobox 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MICU1
|
mitochondrial calcium uptake 1
|
|
MIR106B
|
microRNA 106b
|
|
MIR10A
|
microRNA 10a
|
|
MIR146A
|
microRNA 146a
|
|
MIR155
|
microRNA 155
|
|
MIR155HG
|
MIR155 host gene
|
|
MIR17
|
microRNA 17
|
|
MIR199B
|
microRNA 199b
|
|
MIR20A
|
microRNA 20a
|
|
MIR34A
|
microRNA 34a
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSI2
|
musashi RNA-binding protein 2
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT1X
|
metallothionein 1X
|
|
MTA1
|
metastasis associated 1
|
|
MTA2
|
metastasis associated 1 family, member 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRNR2L1
|
MT-RNR2-like 1
|
|
MTRNR2L10
|
MT-RNR2-like 10
|
|
MTRNR2L2
|
MT-RNR2-like 2
|
|
MTRNR2L3
|
MT-RNR2-like 3
|
|
MTRNR2L4
|
MT-RNR2-like 4
|
|
MTRNR2L5
|
MT-RNR2-like 5
|
|
MTRNR2L6
|
MT-RNR2-like 6
|
|
MTRNR2L7
|
MT-RNR2-like 7
|
|
MTRNR2L8
|
MT-RNR2-like 8
|
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
MXRA5
|
matrix-remodelling associated 5
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH14
|
myosin, heavy chain 14, non-muscle
|
|
MYO7A
|
myosin VIIA
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOTCH1
|
notch 1
|
|
NOTCH4
|
notch 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPRL2
|
nitrogen permease regulator-like 2 (S. cerevisiae)
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUMA1
|
nuclear mitotic apparatus protein 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PAX9
|
paired box 9
|
|
PCDH15
|
protocadherin-related 15
|
|
PDE6H
|
phosphodiesterase 6H, cGMP-specific, cone, gamma
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDZK1
|
PDZ domain containing 1
|
|
PER2
|
period circadian clock 2
|
|
PEX19
|
peroxisomal biogenesis factor 19
|
|
PICALM
|
phosphatidylinositol binding clathrin assembly protein
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PPAP2A
|
phosphatidic acid phosphatase type 2A
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP2R2B
|
protein phosphatase 2, regulatory subunit B, beta
|
|
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4
|
|
PRDX2
|
peroxiredoxin 2
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRMT1
|
protein arginine methyltransferase 1
|
|
PROM1
|
prominin 1
|
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
PTBP1
|
polypyrimidine tract binding protein 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTMA
|
prothymosin, alpha
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RBBP5
|
retinoblastoma binding protein 5
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHOA
|
ras homolog family member A
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRH
|
retinal pigment epithelium-derived rhodopsin homolog
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
S100A11
|
S100 calcium binding protein A11
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C
|
|
SEMG1
|
semenogelin I
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SETMAR
|
SET domain and mariner transposase fusion gene
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIM1
|
single-minded family bHLH transcription factor 1
|
|
SIM2
|
single-minded family bHLH transcription factor 2
|
|
SLC22A11
|
solute carrier family 22 (organic anion/urate transporter), member 11
|
|
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A3R1
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SP7
|
Sp7 transcription factor
|
|
SPA17
|
sperm autoantigenic protein 17
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
|
SRA1
|
steroid receptor RNA activator 1
|
|
SRSF7
|
serine/arginine-rich splicing factor 7
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
TAAR1
|
trace amine associated receptor 1
|
|
TAAR2
|
trace amine associated receptor 2
|
|
TAAR3
|
trace amine associated receptor 3 (gene/pseudogene)
|
|
TAAR4P
|
trace amine associated receptor 4, pseudogene
|
|
TAAR5
|
trace amine associated receptor 5
|
|
TAAR6
|
trace amine associated receptor 6
|
|
TAAR7P
|
trace amine associated receptor 7, pseudogene
|
|
TAAR8
|
trace amine associated receptor 8
|
|
TAAR9
|
trace amine associated receptor 9 (gene/pseudogene)
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAL1
|
T-cell acute lymphocytic leukemia 1
|
|
TCERG1
|
transcription elongation regulator 1
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
THOC5
|
THO complex 5
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TMEM107
|
transmembrane protein 107
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPP1
|
tripeptidyl peptidase I
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
UMOD
|
uromodulin
|
|
UMPS
|
uridine monophosphate synthetase
|
|
URI1
|
URI1, prefoldin-like chaperone
|
|
USB1
|
U6 snRNA biogenesis 1
|
|
USP9X
|
ubiquitin specific peptidase 9, X-linked
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VWF
|
von Willebrand factor
|
|
WDR17
|
WD repeat domain 17
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WHSC1L1
|
Wolf-Hirschhorn syndrome candidate 1-like 1
|
|
WRNIP1
|
Werner helicase interacting protein 1
|
|
XBP1
|
X-box binding protein 1
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
|
ZKSCAN3
|
zinc finger with KRAB and SCAN domains 3
|
|
ZNF217
|
zinc finger protein 217
|
|
ZNF804A
|
zinc finger protein 804A
|
